JP2006312034A - Nasolacrimal duct tube - Google Patents

Nasolacrimal duct tube Download PDF

Info

Publication number
JP2006312034A
JP2006312034A JP2006105988A JP2006105988A JP2006312034A JP 2006312034 A JP2006312034 A JP 2006312034A JP 2006105988 A JP2006105988 A JP 2006105988A JP 2006105988 A JP2006105988 A JP 2006105988A JP 2006312034 A JP2006312034 A JP 2006312034A
Authority
JP
Japan
Prior art keywords
tube
nasolacrimal duct
polyurethane
lacrimal
marking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006105988A
Other languages
Japanese (ja)
Inventor
Hiroshi Wakuta
弘 和久田
Satoru Inoue
井上  悟
Tokihiko Uchida
時彦 内田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2006105988A priority Critical patent/JP2006312034A/en
Publication of JP2006312034A publication Critical patent/JP2006312034A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Surgical Instruments (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a nasolacrimal duct tube to be used for operation of reforming a lacrimal channel, wherein a bougie can be easily inserted and infection risk during indwelling is suppressed so as to ensure high safety without problems that the tube is detached during operation, mucosa is damaged while inserted and a temporary channel is formed, and the like, by forming a tube end part of an integrated polyurethane tube into a hemispherical shape, thinning a central part, and marking a mark in a circumference of a slit or hole for bougie. <P>SOLUTION: The nasolacrimal duct tube, wherein affection risk during indwelling is suppressed so as to ensure high safety without problems that the tube is detached during operation, mucosa is damaged while inserted and a temporary channel is formed, and the like, is provided for operation of reforming the lacrimal channel using a silicone tube. The penetrating strength of a bougie can be further raised by applying polyurethane with Shore A hardness higher than that of the tube main body, on the inside of a blind end. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、特に、流涙症の治療のために、涙点、涙小菅、涙嚢、鼻涙管の涙道を再形成する手術に用いる鼻涙管チューブに関する。   In particular, the present invention relates to a nasolacrimal duct tube for use in surgery to reshape the lacrimal punctum, lacrimal folds, lacrimal sac, and nasolacrimal duct for the treatment of lacrimation.

人間の目と鼻の部分は図1に示すようになっており、目の内部はその鼻側の上下に開口する上涙点1および下涙点2に連通している。そして、上涙小菅3と下涙小菅4は総涙小菅5を経て涙嚢6に連なっている。この涙嚢6は下方に向かって延びる鼻涙管7に連通し、最終的に鼻腔につながっている。以上のような涙点、涙小菅、涙嚢、鼻涙管等が閉塞すると涙を鼻腔内に逃がすことができず、いわゆる流涙症となる。そこでこれら涙点、涙小菅、涙嚢、鼻涙管等を含む涙道閉塞の治療法として、涙道内にシリコーンチューブ又はポリウレタンチューブを挿入留置する方法が実施され、有用性が確認されている。例えば、シリコーンチューブとしては、特許文献1で、端部がとがって封止された構造のシリコーンチューブとその使用方法が提案されている。また、ポリウレタンチューブとしては、特許文献2で、留置チューブがポリウレタンで、探子チューブ部分がポリオレフィン、ポリアミド、又はポリウレタンの構造のものとその使用方法が提案されている。
特開平6−142129号公報 特開2001−327525号公報
The human eye and nose are as shown in FIG. 1, and the inside of the eye communicates with the upper punctum 1 and the lower punctum 2 that open up and down on the nose side. The upper tear gavel 3 and the lower tear gavel 4 are connected to the lacrimal sac 6 through the total tear gavel 5. The lacrimal sac 6 communicates with a nasolacrimal duct 7 extending downward, and finally is connected to the nasal cavity. When the punctum, lacrimal fistula, lacrimal sac, nasolacrimal duct, and the like as described above are blocked, tears cannot escape into the nasal cavity, resulting in so-called lacrimation. Thus, as a treatment method for lacrimal passage obstruction including these punctum, lacrimal fistula, lacrimal sac, nasolacrimal duct, etc., a method of inserting and placing a silicone tube or polyurethane tube into the lacrimal passage has been implemented and its usefulness has been confirmed. For example, as a silicone tube, Patent Document 1 proposes a silicone tube having a structure in which an end portion is cut off and sealed, and a method of using the silicone tube. Patent Document 2 proposes a polyurethane tube having a structure in which the indwelling tube is made of polyurethane and the probe tube portion is made of polyolefin, polyamide, or polyurethane, and a method of using the same.
JP-A-6-142129 JP 2001-327525 A

しかし、特許文献1のシリコーンチューブにおいては、シリコーンチューブを涙点に挿入し、涙道内を進めようとする際、または留置チューブを引き抜く際シリコーンチューブは強度が低いため、手技中に離脱する恐れがあり、チューブ端部がとがっているものは涙道挿入時に粘膜等を傷つけたり仮道を形成する恐れがある。また、留置中のシリコーンチューブ表面についた汚れに起因する感染やそれに起因すると考えられる肉芽形成も問題となっている。一方、特許文献2のポリウレタンチューブにおいては、チューブ先端の探子チューブ部分もポリウレタンであっても、接着等で接合しているため探子チューブ部分が離脱する危険性がある。また、シリコーンチューブにおいても、ポリウレタンチューブにおいても消息子(ブジー:鼻涙管を涙道に挿入するための専用の器具)を挿入する数ミリの長さの小さな切れ目または孔は視認性が悪く、細い消息子を挿入するとき、その位置の確認が目視で明確に把握出来ないため、挿入作業に手間がかかっていた。   However, in the silicone tube of Patent Document 1, when the silicone tube is inserted into the punctum and is going to advance in the lacrimal passage, or when the indwelling tube is pulled out, the silicone tube has low strength and may be detached during the procedure. There is a risk of damaging the mucous membrane or the like or forming a temporary tract when the lacrimal passage is inserted. In addition, infection caused by dirt on the surface of the silicone tube during indwelling and granulation formation considered to be caused by it are also problematic. On the other hand, in the polyurethane tube of Patent Document 2, there is a risk that the probe tube portion may be detached because the probe tube portion at the tip of the tube is bonded by adhesion or the like even if it is polyurethane. In addition, in both silicone tubes and polyurethane tubes, small cuts or holes with a length of a few millimeters for inserting the extinguisher (bougie: a dedicated instrument for inserting the nasolacrimal duct into the lacrimal passage) are poorly visible, When inserting a thin tape, it was difficult to see the position clearly, so it took a lot of work to insert it.

本発明は、上記課題を解決するため、主として以下の構成を有する。すなわち、
(1)一体に形成されたチューブの両方の終端の外面が略半円球状で、内面は終端側を頂点とする略円錐形状であることを特徴とする鼻涙管チューブ、
(2)前記チューブに消息子を挿入する開口を有し、該開口の周囲にマーキングを有することを特徴とする(1)記載の鼻涙管チューブ、
(3)前記チューブの内面の一部または全面に、チューブ本体の材料よりもショアA硬度が高い材料が塗布されていることを特徴とする(1)または(2)に記載の鼻涙管チューブ、
(4)前記のチューブの材料がポリウレタンゴムであることを特徴とする(1)〜(3)のいずれかに記載の鼻涙管チューブ、
(5)前記終端の肉厚がチューブ肉厚よりも厚いことを特徴とする(1)〜(4)のいずれかに記載の鼻涙管チューブ、
(6)チューブの両端部の太さは中央部よりも太く、両端部と中央部の境界がなだらかな段差となっていることを特徴とする(1)〜(5)のいずれかに記載の涙道再形成術に用いる鼻涙管チューブ、
(7)材料がポリウレタンからなり、1.2〜10倍に伸ばしたときに剥離することのないマーキングを有することを特徴とする(1)〜(6)のいずれかに記載の鼻涙管チューブ、
である。
In order to solve the above problems, the present invention mainly has the following configuration. That is,
(1) A nasolacrimal duct tube characterized in that the outer surfaces of both ends of the integrally formed tube are substantially hemispherical, and the inner surface has a substantially conical shape with the end side as a vertex.
(2) The nasolacrimal duct tube according to (1), characterized in that the tube has an opening for inserting an extinguisher and has a marking around the opening.
(3) The nasolacrimal duct tube according to (1) or (2), wherein a material having a Shore A hardness higher than the material of the tube body is applied to a part or the entire inner surface of the tube. ,
(4) The nasolacrimal duct tube according to any one of (1) to (3), wherein the tube material is polyurethane rubber,
(5) The nasolacrimal duct tube according to any one of (1) to (4), wherein the thickness of the terminal end is thicker than the tube thickness,
(6) The thickness of both ends of the tube is thicker than the central portion, and the boundary between the both ends and the central portion is a gentle step, which is described in any one of (1) to (5) Nasolacrimal duct tube used for lacrimal passage remodeling,
(7) The nasolacrimal duct tube according to any one of (1) to (6), wherein the material is made of polyurethane and has a marking that does not peel when stretched 1.2 to 10 times. ,
It is.

本発明の鼻涙管チューブは、一体のチューブ(ポリウレタン材料等)として構成されているため強度が高く、手技中にチューブが離脱する可能性が小さい。また、先端が丸く、表面が滑らかであるため、涙道挿入時に粘膜等を傷つけたり仮道を形成する恐れが少なく、また留置中のチューブの移動、感染リスクを抑える、安全性の高い涙道再形成手術に用いる鼻涙管チューブを提供することができる。   Since the nasolacrimal duct tube of the present invention is configured as an integral tube (polyurethane material or the like), the strength is high, and the possibility that the tube is detached during the procedure is small. In addition, because the tip is round and the surface is smooth, there is little risk of damaging the mucous membrane or forming a temporary passage when inserting the lacrimal passage, and the highly safe lacrimal passage that suppresses the risk of moving the tube during infection or infection. A nasolacrimal duct tube for use in remodeling surgery can be provided.

本発明の鼻涙管チューブは、涙道に挿入可能な径をもつチューブにおいて、チューブ本体が樹脂材料により一体に形成されているものである。ここで、一体に形成されるとは、接着等によって各部分を接合したものではなく、一体の素材で構成されることを言う。   The nasolacrimal duct tube of the present invention is a tube having a diameter that can be inserted into the lacrimal passage, and the tube body is integrally formed of a resin material. Here, being integrally formed means that each part is not joined by bonding or the like, but is constituted by an integral material.

鼻涙管チューブはしなやかさが要求されるため、チューブ本体の硬さはショアA硬度で70〜100であることが好ましく、72〜95であることがより好ましい。なお、ここでいうショアA硬度とは、JISZ2246(2000)で測定した値をいう。   Since the nasolacrimal duct tube is required to be flexible, the hardness of the tube body is preferably 70 to 100 in Shore A hardness, and more preferably 72 to 95. Here, the Shore A hardness is a value measured according to JISZ2246 (2000).

なお、チューブを形成する樹脂材料としては生体に悪影響を及ぼさない樹脂であれば特に限定されないが、なかでもポリウレタン、シリコーンが好ましく、ポリウレタンがより好ましい。   The resin material forming the tube is not particularly limited as long as it does not adversely affect the living body, but polyurethane and silicone are preferable, and polyurethane is more preferable.

チューブ本体は径が略均一のものでもかまわないが、図2に示すように両端太径部13と中央細径部9からなることが好ましい。   The tube body may have a substantially uniform diameter, but it is preferable that the tube body is composed of a large diameter portion 13 at both ends and a central small diameter portion 9 as shown in FIG.

両端太径部13のチューブ内径は消息子(ブジー)を挿入できる径であれば特に限定されないが、例えば0.2〜2.0mm程度が好ましく、さらに好ましくは例えば0.5〜0.7mm程度である。また、両端太径部13のチューブ外径は鼻涙管に挿入できる太さであれば特に限定されないが、例えば0.3〜3.0mm程度が好ましく、さらに好ましくは例えば1.0〜1.2mm程度である。   The inner diameter of the tube 13 at both ends is not particularly limited as long as it is a diameter capable of inserting a buzzer, but is preferably about 0.2 to 2.0 mm, more preferably about 0.5 to 0.7 mm, for example. It is. Further, the outer diameter of the tube at both ends of the large diameter portion 13 is not particularly limited as long as it can be inserted into the nasolacrimal duct, but is preferably about 0.3 to 3.0 mm, and more preferably, for example, 1.0 to 1. It is about 2 mm.

両端太径部13には図2のように両先端から所定の距離を置いた位置に開口11が2つ形成されている。この開口11は消息子(ブジー)をチューブに挿入するためのものである。開口11の位置は、先端からの長さが20〜100mm程度の位置が好ましく、さらに好ましくは25〜55mm程度である。なお、開口の数は3つ以上であってもかまわない。   Two openings 11 are formed in the large-diameter portions 13 at both ends at a position spaced a predetermined distance from both ends as shown in FIG. This opening 11 is for inserting a bougie into the tube. The position of the opening 11 is preferably a position having a length from the tip of about 20 to 100 mm, more preferably about 25 to 55 mm. The number of openings may be three or more.

開口11の形状は、切れ目をいれただけのスリット(図4)であっても、円、楕円、長円、短冊形等の孔(図6)であってもかまわないが、好ましくは孔である。開口11の大きさは消息子(ブジー)を挿入するのに必要にして十分な大きさであれば特に限定されない。具体的には孔ならば長径1〜2mm程度、スリットであれば長さ1〜2mm程度が好ましい。開口11の周囲には図5及び図7の様にマーキング(着色)することが好ましい。このマーキングによって消息子(ブジー)の挿入位置を即座に確認できるという効果を奏する。特に孔の周囲にマーキングした場合(図7)は視認性が高く、極めて好ましい。なお、マーキングの素材は当分野で通常しされている染料、顔料、塗料等を用いることができる。   The shape of the opening 11 may be a slit (FIG. 4) with only a cut, or a hole (FIG. 6) such as a circle, an ellipse, an ellipse, a strip, etc. is there. The size of the opening 11 is not particularly limited as long as the opening 11 is large enough to be inserted for inserting a bougie. Specifically, the major axis is preferably about 1 to 2 mm in length, and the slit is preferably about 1 to 2 mm in length. The periphery of the opening 11 is preferably marked (colored) as shown in FIGS. This marking has the effect that the insertion position of the bougie can be confirmed immediately. In particular, when marking is made around the hole (FIG. 7), the visibility is high, which is extremely preferable. As the marking material, dyes, pigments, paints and the like which are commonly used in this field can be used.

なお、開口11周辺の他、手技の際の目印となるように、チューブ中央部やその他の位置に、マーキングすることも好ましく行われる。マーキングに使用する材料としては、チューブを涙道に挿入するとき、あるいは留置したチューブを取り出すときにチューブが伸びても剥離しないものが好ましい。具体的には、チューブを任意の方向に1.2〜10倍に伸ばしたときであっても、剥離しない性質を有するものが好ましい。さらに好ましくは涙道内でマーキングの材料が擦れても剥離しないものが好ましい。具体例をあげると、ナビタス(株)のパッドインキPAD−SPS黒があり、これに補強剤および溶剤を所定の重量比にて混合して作ったパッド印刷用インク等が好ましい。   In addition to the periphery of the opening 11, marking is preferably performed at the center of the tube and other positions so as to be a mark for the procedure. As a material used for marking, a material that does not peel even when the tube extends when the tube is inserted into the lacrimal passage or when the placed tube is taken out is preferable. Specifically, it is preferable to have a property that does not peel even when the tube is extended 1.2 to 10 times in an arbitrary direction. More preferably, the marking material does not peel even if it is rubbed in the lacrimal passage. As a specific example, there is a pad ink PAD-SPS black manufactured by Navitas Co., Ltd., and a pad printing ink made by mixing a reinforcing agent and a solvent in a predetermined weight ratio is preferable.

中央細径部9は両端太径部を連結する役割を有する。中央細径部9の内径は例えば0.2〜2.0mm程度が好ましく、さらに好ましくは例えば0.3〜0.5mm程度である。中央細径部9の外径は例えば0.3〜3.0mm程度が好ましく、さらに好ましくは例えば0.6〜0.8mm程度である。   The central small diameter portion 9 has a role of connecting the large diameter portions at both ends. The inner diameter of the central small diameter portion 9 is preferably about 0.2 to 2.0 mm, and more preferably about 0.3 to 0.5 mm, for example. The outer diameter of the central small diameter portion 9 is preferably about 0.3 to 3.0 mm, and more preferably about 0.6 to 0.8 mm, for example.

両端太径部13と中央細径部9の境界はなだらかな段差になっていることが好ましい。段差をなだらかにすることにより、涙道への挿入、抜去をスムースに行うことができる。中央細径部9の長さは25〜35mmが好ましく、さらに好ましくは例えば27〜33mm程度である。また、両端太径部13の長さは、それぞれ30〜50mmが好ましい。   The boundary between the large-diameter portion 13 at both ends and the central thin-diameter portion 9 is preferably a gentle step. By smoothing the step, it is possible to smoothly insert and remove the lacrimal passage. The length of the central small diameter portion 9 is preferably 25 to 35 mm, and more preferably about 27 to 33 mm. Moreover, as for the length of the both ends large diameter part 13, 30-50 mm is respectively preferable.

チューブ両端の終端12は丸く滑らかであることが好ましく、さらに好ましくは略半円球状になっていることが好ましい。ここで、本発明における略半円球状とは、丸く滑らかな円球形状または楕円球形状の一部の形状であるものが含まれ、終端が曲面を有していればよい。好ましくは、両端太径部13と終端12との境界線34(図2参照)における断面における中心点を半円球の中心点と見立てたとき、かかる中心点からの終端における任意の位置の半径の最小値がその最大値の60%以上であるような形状をいう。両端の終端12の厚み(チューブ長手方向の厚み)は0.3〜1.5mmが好ましく、さらに好ましくは例えば0.4〜1.0mm程度である。終端の厚み33はチューブ本体の厚みよりも厚いことが、消息子(ブジー)の突き抜け防止の観点から好ましい。終端の内部は終端側を頂点とする略円錐形状であることがよく、なだらかな略円錐形状になっていることが好ましい。消息子をチューブ内部においてその終端まで導く際、消息子先端に対する突き抜け強度が強いチューブ先端に導く前に、突き抜け強度が弱いチューブ側面から消息子先端が突き抜けないようにするため、消息子をチューブ断面における中央付近に誘導する必要があるが、終端内部が略円錐形状であることにより、容易に消息子をチューブ断面側における中央付近に誘導することが可能となる。すなわち、本発明でいう略円錐形状とは、内面がテーパーを有し、かつ終端に向かって先細りしている形状のものであればよく、例えば、角のない丸い形状の頂点を有する形状、楕円形の底面を有する形状のものを含むものである。具体的には円錐形状部の長さは3mm程度が好ましい。なお、終端の内部が円錐形状であることから、終端部分の厚みは一様ではなく、これが強度保持、突き抜け強度の向上に繋がるものと考えられる。   The ends 12 at both ends of the tube are preferably round and smooth, and more preferably substantially semi-spherical. Here, the substantially semispherical shape in the present invention includes a round and smooth circular sphere or a part of an elliptic sphere, and it is only necessary that the terminal end has a curved surface. Preferably, when the center point in the cross section at the boundary line 34 (see FIG. 2) between the large-diameter portions 13 at both ends and the end 12 is regarded as the center point of the hemisphere, the radius of an arbitrary position at the end from the center point A shape whose minimum value is 60% or more of the maximum value. The thickness of the end 12 at both ends (thickness in the tube longitudinal direction) is preferably 0.3 to 1.5 mm, and more preferably about 0.4 to 1.0 mm, for example. The thickness 33 of the terminal end is preferably thicker than the thickness of the tube body from the viewpoint of preventing penetration of the bougie. The inside of the terminal end may have a substantially conical shape with the end side as a vertex, and preferably has a gentle substantially conical shape. When guiding the extinguisher to its end in the tube, before guiding it to the tube tip where the penetrating strength against the extinguisher tip is strong, to prevent the extinguisher tip from penetrating from the side of the tube where the penetrating strength is weak, However, since the inside of the terminal end has a substantially conical shape, it is possible to easily guide the extinguisher near the center on the tube cross section side. That is, the substantially conical shape referred to in the present invention is not limited as long as the inner surface has a taper and is tapered toward the end, for example, a shape having a round apex with no corners, an ellipse Includes shapes having a bottom surface. Specifically, the length of the conical portion is preferably about 3 mm. In addition, since the inside of the terminal end has a conical shape, the thickness of the terminal end portion is not uniform, which is considered to lead to strength maintenance and improvement of punch-through strength.

チューブの全長は80〜120mmが好ましく、さらに好ましくは例えば90〜110mm程度である。   The total length of the tube is preferably 80 to 120 mm, more preferably about 90 to 110 mm, for example.

本発明の鼻涙管チューブは、チューブ本体の内面の一部または全面に、チューブ本体の材料よりもショアA硬度が高い材料17が塗布されていることが好ましい。特に、チューブ本体の材料と同じ材質でショアA硬度が高いものを用いることがより好ましい。例えば、チューブ本体がショアA硬度74のポリウレタンであれば、内面にはショアA硬度93のポリウレタンを塗布する。このように構成することによって、チューブ本体の有する柔軟性を失わずに、突き抜け強度を向上させることができる。なお、塗布する部分についてはチューブの内面全体であっても良いが、両端太径部13の内面のみであっても良いし、両端太径部13の内面の一部、特に終端側の一部であっても良い。   In the nasolacrimal duct tube of the present invention, a material 17 having a Shore A hardness higher than that of the material of the tube body is preferably applied to a part or the entire surface of the inner surface of the tube body. In particular, it is more preferable to use a material having the same Shore A hardness as the material of the tube body. For example, if the tube body is polyurethane with a Shore A hardness of 74, a polyurethane with a Shore A hardness of 93 is applied to the inner surface. By comprising in this way, penetration strength can be improved, without losing the softness | flexibility which a tube main body has. In addition, although it may be the whole inner surface of a tube about the part to apply | coat, only the inner surface of both ends large diameter part 13 may be sufficient, and a part of inner surface of both ends large diameter part 13, especially a part by the side of a termination | terminus It may be.

次に本発明の鼻涙管チューブの製造方法について、以下ポリウレタンを例にとって説明する。   Next, the manufacturing method of the nasolacrimal duct tube of the present invention will be described below using polyurethane as an example.

ポリウレタンを、例えば押し出し成形し、所望の外径及び内径のポリウレタンチューブを作製する。チューブ自体は市販のものを使用してもかまわない。図2のようにチューブ本体に両端太径部と中央細径部を設ける場合は、例えば径の均一なチューブを引き伸ばした状態で中央部を加熱後、冷却する等の方法により、両端太径部と中央細径部を形成することができる。   Polyurethane is extruded, for example, to produce a polyurethane tube having a desired outer diameter and inner diameter. A commercially available tube may be used. When the tube main body is provided with a large-diameter portion at both ends and a small-diameter portion at the center as shown in FIG. And a central small diameter portion can be formed.

所望の長さにチューブをカットした後、終端を封止する。終端は、例えば加熱された金属等に近づけて、溶融させることにより封止することができる。この場合、加熱体にチューブを接触させてしまうと終端を丸くするのが困難なので、接触させずに放射熱で溶融封止する。このような溶融封止方法によれば、終端外面が丸く滑らかに封止されると共に、終端内部がなだらかな円錐形状とすることができる。もちろん、終端を丸く滑らかにできさらに内部を円錐形状にできれば、上記方法に限定されることがないのはいうまでもない。   After the tube is cut to the desired length, the end is sealed. The end can be sealed by, for example, bringing it close to a heated metal or the like and melting it. In this case, if the tube is brought into contact with the heating body, it is difficult to round the end, and therefore, the sealing is performed by radiant heat without contact. According to such a melt-sealing method, the outer surface of the terminal end is round and smoothly sealed, and the inside of the terminal end can be formed into a gentle conical shape. Of course, it is needless to say that the method is not limited to the above method as long as the end can be made round and smooth and the inside can be made conical.

なお、チューブ内面を、チューブ本体の材料よりもショアA硬度が高い材料で塗布する場合には、終端を封止する前に、前記材料を溶解した溶液等をチューブ内部に注入、乾燥し、前記材料を塗布する。溶液を内部に注入する方法としては、例えばシリンジ等で注入する方法、チューブ終端を溶液に漬けて陰圧をかけて溶液を吸い上げる方法等がある。チューブの内径にもよるが、溶液に溶解した前記材料の濃度等によって塗布する厚みをコントロールすることができる。チューブの内層に外層となるチューブ本体の材料よりショア硬度の高い材料を使用した2層チューブを使用すれば、チューブ本体の内部に塗布する必要はなくなる。   When applying the inner surface of the tube with a material having a Shore A hardness higher than the material of the tube body, before sealing the end, a solution or the like in which the material is dissolved is poured into the tube and dried, Apply material. As a method for injecting the solution into the inside, for example, there are a method of injecting with a syringe or the like, a method of immersing the tube end in the solution and applying a negative pressure to suck up the solution. Although depending on the inner diameter of the tube, the coating thickness can be controlled by the concentration of the material dissolved in the solution. If a two-layer tube using a material having a higher Shore hardness than the material of the tube main body serving as the outer layer is used as the inner layer of the tube, it is not necessary to apply it to the inside of the tube main body.

開口は所望の位置に、カッターによるカッティング、パンチング、溶融等により所望の大きさのスリットまたは孔を設ける。その後、開口周辺にマーキングを施す。   The opening is provided with a slit or hole of a desired size at a desired position by cutting, punching, melting or the like with a cutter. Thereafter, marking is performed around the opening.

このようにして製造した本発明の鼻涙管チューブは、一体のポリウレタンで構成されているため強度が高い。また、終端が丸く、表面が滑らかであるため、涙道挿入時に粘膜等を傷つけたり仮道を形成する恐れが少ない。さらに、終端内部はなだらかな円錐形状であるため、消息子(ブジー)を挿入したときに消息子(ブジー)先端がチューブ中央側へ案内され側面を突き破るといった可能性も減らすことができる。また、終端はショア硬度の高いポリウレタンと終端厚みが厚いことで突き抜け強度が強化されているため先端を突き破るという可能性も減らすことができる。   The nasolacrimal duct tube of the present invention thus manufactured has a high strength because it is made of integral polyurethane. In addition, since the end is round and the surface is smooth, there is little risk of damaging the mucous membrane or the like or forming a temporary path when inserting the lacrimal passage. Furthermore, since the inside of the terminal end has a gentle conical shape, it is possible to reduce the possibility that, when the extinguisher (bougie) is inserted, the extremity (bougie) tip is guided to the tube center side and breaks through the side surface. Moreover, since the penetration strength is strengthened by the polyurethane having a high Shore hardness and the termination thickness being thick, the possibility of breaking through the tip can be reduced.

以下に実施例によって本発明を詳細に説明するが、本発明はこれに限られるものではない。   Hereinafter, the present invention will be described in detail by way of examples, but the present invention is not limited thereto.

[実施例1]
外径1.0mm、内径0.6mmのポリウレタンチューブ(テコタンTT−1074A、サーメディックス社製、ショアA硬度74)を押し出し成形により作製後、チューブを1.4倍に伸ばした状態で中央部の細くしたい部分(長さ30mm)以外をカバーしてお湯に一定時間漬けた後、冷却して細径部を作った。
[Example 1]
A polyurethane tube with an outer diameter of 1.0 mm and an inner diameter of 0.6 mm (Tecotan TT-1074A, manufactured by Thermedix Corp., Shore A hardness 74) was prepared by extrusion molding. The portion other than the portion to be thinned (30 mm in length) was covered and soaked in hot water for a certain period of time, and then cooled to form a small diameter portion.

細径部30mmを中心にして全長が97mmになるよう両端をカット後、消息子用の孔を2個所に開けた。孔の位置は各端面から長円内側までが28mmで、形状は幅0.3mm全長2mmの長円とした。その後、220℃の熱板に接触させることなくチューブ終端面を近づけ、終端を封止した。終端は滑らかな略半円球状になると共に、終端の厚みが約1mmになるまで熱板にかざした。他方のチューブ終端面も同様に加工した結果、全長が90mmの一体構成の鼻涙管チューブを作製することが出来た。消息子用の孔の全周に油性マジックで印を付けたら、孔の位置を目視ではっきり確認が出来、消息子の挿入がきわめて容易に出来た。   After cutting both ends so that the total length becomes 97 mm centering on the small diameter part 30 mm, two holes for the extinguisher were opened. The position of the hole was 28 mm from each end face to the inside of the ellipse, and the shape was an ellipse having a width of 0.3 mm and a total length of 2 mm. Thereafter, the end face of the tube was brought closer without being brought into contact with a hot plate at 220 ° C., and the end was sealed. The end became a smooth semi-spherical shape and was held over a hot plate until the end thickness was about 1 mm. As a result of processing the other tube end face in the same manner, an integrated nasolacrimal tube having a total length of 90 mm could be produced. When the perimeter of the hole for the son was marked with an oil-based magic, the position of the hole could be clearly confirmed by visual observation, and the insertion of the son could be done very easily.

[実施例2]
実施例1と同様に終端を加工する前の段階まで作製後、チューブ両端からテトラヒドロフランにポリウレタン(テコフレックスEG93A、サーメディックス社製、ショアA硬度93)を10重量%溶解した溶液を陰圧で吸い上げた後、乾燥して内面に薄く塗布した。その後、実施例1と同様に両終端を略半円球状に作製した。ショアA硬度が高いポリウレタンを内面に塗布したときの効果を図8、9の測定冶具を使用してそれぞれ5本ずつ終端から3mmの位置の側面突き抜け強度をテンシロン万能試験機(RTA−100、オリエンテック社製)にて、クロスヘッドスピード30mm/分、チャック間距離20mmの条件で圧縮試験で測定したところ表1の結果(平均値)が得られた。シリコン製の鼻涙管チューブとの比較例としては、外径1.0mm内径0.5mmのシラスコン医療用チューブ、カネカメディックス社製を使用した。
[Example 2]
After the preparation up to the stage before the end was processed in the same manner as in Example 1, a solution of 10% by weight of polyurethane (Tecoflex EG93A, manufactured by Thermedix, Shore A hardness 93) dissolved in tetrahydrofuran was sucked up by negative pressure from both ends of the tube. Then, it was dried and thinly applied to the inner surface. Thereafter, both ends were formed in a substantially semispherical shape in the same manner as in Example 1. The effect of applying polyurethane with high Shore A hardness on the inner surface was measured using the measuring jigs shown in FIGS. 8 and 9, and the side penetration strength at a position of 3 mm from the end of each was measured with Tensilon Universal Testing Machine (RTA-100, Oriente Measured by a compression test under the conditions of a crosshead speed of 30 mm / min and a distance between chucks of 20 mm, the results shown in Table 1 (average values) were obtained. As a comparative example with a nasolacrimal duct tube made of silicon, a Shirasukon medical tube having an outer diameter of 1.0 mm and an inner diameter of 0.5 mm, manufactured by Kaneka Medix Co., Ltd. was used.

Figure 2006312034
Figure 2006312034

実施例1及び比較例に比べて、実施例2の方が側面突き抜け強度が高く、より安全といえる。   Compared to Example 1 and Comparative Example, Example 2 has higher side penetration strength and can be said to be safer.

[実施例3]
実施例2と同様に、鼻涙管チューブを作製した。ショアA硬度が高いポリウレタンを内面に塗布したときの効果を図10の測定冶具を使用してそれぞれ5本ずつ先端突き抜け強度をテンシロン万能試験機(RTA−100、オリエンテック社製)にて、クロスヘッドスピード30mm/分、チャック間距離20mmの条件で圧縮試験で測定したところ表2の結果(平均値)が得られた。
[Example 3]
A nasolacrimal duct tube was produced in the same manner as in Example 2. The effect of applying polyurethane with high Shore A hardness on the inner surface was measured using a measuring jig shown in FIG. 10 and the tip penetration strength was crossed with a Tensilon universal testing machine (RTA-100, manufactured by Orientec Corp.). When measured in a compression test under the conditions of a head speed of 30 mm / min and a distance between chucks of 20 mm, the results shown in Table 2 (average values) were obtained.

Figure 2006312034
Figure 2006312034

実施例1に比べて、実施例3の方が先端突き抜け強度が高く、より安全といえる。 Compared to Example 1, Example 3 has higher tip penetration strength and can be said to be safer.

[実施例4]
実施例1と同様に、鼻涙管チューブを作製した。消息子用の孔の全周と鼻涙管チューブの片方の端から鼻涙管チューブが涙道にどれだけ挿入されたかを判定できる深度マークを該チューブの端から5mm間隔で1mm幅×1mm長さで8個所に、ナビタス(株)のパッドインキPAD−SPS黒と補強剤JA940溶剤SGA遅乾を重量比10:2:3で混合して作ったパッド印刷用インクを使用し、ナビタス(株)のパッド印刷機NEAT−70Bを使用して印を付けたところ、消息子用の孔の位置を目視ではっきり確認でき、消息子の挿入がきわめて容易に出来た。また、深度マークも明瞭に印刷することができた。
[Example 4]
A nasolacrimal duct tube was produced in the same manner as in Example 1. Depth marks that can determine how much the nasolacrimal duct tube has been inserted into the lacrimal passage from one end of the nasolacrimal duct tube and 1 mm wide x 1 mm long at 5 mm intervals from the end of the tube Now, pad printing ink made by mixing pad ink PAD-SPS black of Navitas Co., Ltd. and reinforcing agent JA940 solvent SGA slow drying at a weight ratio of 10: 2: 3 is used in 8 places. ) Pad printing machine NEAT-70B was used, and the position of the hole for the blank was clearly confirmed by visual observation, so that the blank could be inserted very easily. Also, the depth mark could be printed clearly.

次に、マーキングの剥離強度を確認するため、消息子の孔の全周マークと深度マークがある部分をチューブ長手方向に3倍の長さまで10回伸ばした後、マーキングが剥離していないことを拡大して確認し、さらに爪で10回こすった後、マーキングの剥離が無いことを拡大して確認した。また、留置期間後におけるマーキングの剥離を確認するため、水道水38℃液中で36日間、および恒温恒湿機の内部において60℃・相対湿度80%として36日間強制劣化した鼻涙管チューブについて、前記同様の方法によってマーキングの剥離を確認した結果、剥離しないことが確認できた。   Next, in order to confirm the peel strength of the marking, the part with the all-round mark and depth mark of the hole of the extinguisher is stretched 10 times in the longitudinal direction of the tube to 10 times, and then the marking is not peeled off. After enlarging and checking, and further rubbing 10 times with a nail, it was enlarged and confirmed that there was no peeling of the marking. In addition, in order to confirm the peeling of the markings after the indwelling period, the nasolacrimal duct tube that was forcibly deteriorated for 36 days in a tap water at 38 ° C. and for 36 days at 60 ° C. and a relative humidity of 80% inside the thermostat As a result of confirming the peeling of the marking by the same method as above, it was confirmed that the marking did not peel.

ヒトの涙道を示す概略図。Schematic showing a human lacrimal passage. 本発明の一態様の模式外観を示す正面図。The front view which shows the model external appearance of 1 aspect of this invention. 図2のA−A断面図。AA sectional drawing of FIG. 鼻涙管チューブの開口(スリット形状)の外観図。The external view of opening (slit shape) of a nasolacrimal duct tube. 図4のスリットの周囲にマーキングした態様の外観図。The external view of the aspect marked around the slit of FIG. 鼻涙管チューブの開口(長円孔形状)の一態様の外観図。The external view of one mode of opening (oval hole shape) of a nasolacrimal duct tube. 図6の孔の周囲にマーキングした態様の外観図。The external view of the aspect marked around the hole of FIG. チューブ側面の突き抜け強度試験用測定冶具。Measuring jig for penetration strength test on the side of the tube. 図8のB−B断面図。BB sectional drawing of FIG. 鼻涙管チューブ終端の突き抜け強度試験用測定冶具。Measuring jig for penetration strength test at the end of the nasolacrimal tube.

符号の説明Explanation of symbols

1 上涙点
2 下涙点
3 上涙小管
4 下涙小管
5 総涙小管
6 涙嚢
7 鼻涙管
8 鼻孔
9 中央細径部
10 細径部と太径部の境界
11 周囲にマーキングした開口
12 終端
13 太径部
14 開口
15 終端内部円錐形状
16 中央細径部
17 内面塗布膜
18 太径部
19 開口(スリット形状)
20 スリット周囲の印(マーキング)
21 開口(長円孔形状)
22 孔周囲の印(マーキング)
23 チューブ受け台
24 被測定チューブ
25 突き抜き用消息子
26 チューブ受け孔
27、32 消息子抜け孔
28 終端付きの被測定チューブ
29 終端付きチューブ受け孔
30 終端付きチューブ受け台
31 測定チューブの終端
33 終端厚み
34 両端太径部13と終端12との境界線
DESCRIPTION OF SYMBOLS 1 Upper punctum 2 Lower punctum 3 Upper lacrimal tubule 4 Lower lacrimal tubule 5 Total lacrimal tubule 6 Lacrimal sac 7 Nasal lacrimal duct 8 Nostril 9 Central small diameter part 10 Boundary between narrow diameter part and large diameter part 11 Opening marked around 12 Termination 13 Large diameter portion 14 Opening 15 Termination internal conical shape 16 Central thin diameter portion 17 Inner surface coating film 18 Large diameter portion 19 Opening (slit shape)
20 Marking around the slit
21 Opening (Oval hole shape)
22 Marking around the hole
23 Tube holder 24 Tube to be measured 25 Mouth for punch 26 Tube receiving hole 27, 32 Mouth hole 28 Tube to be measured with termination 29 Tube receiving hole with termination 30 Tube receptacle with termination 31 End of measurement tube 33 End thickness 34 Boundary line between large diameter portion 13 at both ends and end 12

Claims (7)

一体に形成されたチューブの両方の終端の外面が略半円球状で、内面は終端側を頂点とする略円錐形状であることを特徴とする鼻涙管チューブ。   A nasolacrimal duct tube characterized in that the outer surfaces of both ends of the integrally formed tube have a substantially semispherical shape, and the inner surface has a substantially conical shape with the end side as a vertex. 前記チューブに消息子を挿入する開口を有し、該開口の周囲にマーキングを有することを特徴とする請求項1記載の鼻涙管チューブ。   The nasolacrimal duct tube according to claim 1, wherein the tube has an opening for inserting an extremity and has a marking around the opening. 前記チューブの内面の一部または全面に、チューブ本体の材料よりもショアA硬度が高い材料が塗布されていることを特徴とする請求項1または2に記載の鼻涙管チューブ。   The nasolacrimal duct tube according to claim 1 or 2, wherein a material having a Shore A hardness higher than that of the tube main body is applied to a part or the entire inner surface of the tube. 前記のチューブの材料がポリウレタンであることを特徴とする請求項1〜3のいずれかに記載の鼻涙管チューブ。   The nasolacrimal tube according to any one of claims 1 to 3, wherein the tube is made of polyurethane. 前記終端の肉厚がチューブ肉厚よりも厚いことを特徴とする請求項1〜4のいずれかに記載の鼻涙管チューブ。   The nasolacrimal duct tube according to any one of claims 1 to 4, wherein a thickness of the terminal end is larger than a thickness of the tube. チューブの両端部の太さは中央部よりも太く、両端部と中央部の境界がなだらかな段差となっていることを特徴とする請求項1〜5のいずれかに記載の鼻涙管チューブ。   The nasolacrimal duct tube according to any one of claims 1 to 5, wherein the thickness of both ends of the tube is thicker than that of the central portion, and the boundary between both ends and the central portion is a gentle step. 1.2〜10倍に伸ばしたときに剥離することのないマーキングを有することを特徴とする請求項4〜6のいずれかに記載の鼻涙管チューブ。   The nasolacrimal duct tube according to any one of claims 4 to 6, wherein the nasolacrimal duct tube has a marking that does not peel when stretched 1.2 to 10 times.
JP2006105988A 2005-04-07 2006-04-07 Nasolacrimal duct tube Pending JP2006312034A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006105988A JP2006312034A (en) 2005-04-07 2006-04-07 Nasolacrimal duct tube

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005110644 2005-04-07
JP2006105988A JP2006312034A (en) 2005-04-07 2006-04-07 Nasolacrimal duct tube

Publications (1)

Publication Number Publication Date
JP2006312034A true JP2006312034A (en) 2006-11-16

Family

ID=37533770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006105988A Pending JP2006312034A (en) 2005-04-07 2006-04-07 Nasolacrimal duct tube

Country Status (1)

Country Link
JP (1) JP2006312034A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010213957A (en) * 2009-03-18 2010-09-30 Sugimoto Ganka Iin Lacrimal passage treatment instrument
WO2013111435A1 (en) * 2012-01-26 2013-08-01 株式会社カネカ Lacrimal duct tube
WO2014115700A1 (en) * 2013-01-24 2014-07-31 株式会社カネカ Lacrimal duct tube

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142129A (en) * 1992-11-12 1994-05-24 L L C:Kk In-lachrymal gland inserting tube implement
JPH0824285A (en) * 1994-07-15 1996-01-30 M L C:Kk Pipe insertion apparatus for rebuilding tear duct
JPH09276318A (en) * 1996-04-08 1997-10-28 M L C:Kk Insertion tool for pipe in lacrimal duct
JP2001112812A (en) * 1999-08-11 2001-04-24 M L C:Kk Intubrator within laciymal duct
JP2001327525A (en) * 2000-03-14 2001-11-27 Nakagawa Akio Nasolacrimal tube used for lacrimal duct reformation operation and nasolacrimal tube appliance

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142129A (en) * 1992-11-12 1994-05-24 L L C:Kk In-lachrymal gland inserting tube implement
JPH0824285A (en) * 1994-07-15 1996-01-30 M L C:Kk Pipe insertion apparatus for rebuilding tear duct
JPH09276318A (en) * 1996-04-08 1997-10-28 M L C:Kk Insertion tool for pipe in lacrimal duct
JP2001112812A (en) * 1999-08-11 2001-04-24 M L C:Kk Intubrator within laciymal duct
JP2001327525A (en) * 2000-03-14 2001-11-27 Nakagawa Akio Nasolacrimal tube used for lacrimal duct reformation operation and nasolacrimal tube appliance

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010213957A (en) * 2009-03-18 2010-09-30 Sugimoto Ganka Iin Lacrimal passage treatment instrument
WO2013111435A1 (en) * 2012-01-26 2013-08-01 株式会社カネカ Lacrimal duct tube
CN104066405A (en) * 2012-01-26 2014-09-24 株式会社钟化 Lacrimal duct tube
JPWO2013111435A1 (en) * 2012-01-26 2015-05-11 株式会社カネカ Lacrimal tube
WO2014115700A1 (en) * 2013-01-24 2014-07-31 株式会社カネカ Lacrimal duct tube
JPWO2014115700A1 (en) * 2013-01-24 2017-01-26 株式会社カネカ Lacrimal tube
US10058451B2 (en) 2013-01-24 2018-08-28 Kaneka Corporation Lacrimal duct tube

Similar Documents

Publication Publication Date Title
ES2369286T3 (en) MICROQUIRURGICAL PROBE.
JP4509079B2 (en) Shroud molding method
US7169163B2 (en) Transnasal method and catheter for lacrimal system
US6171324B1 (en) Marker for corneal incision
JPH10179734A (en) Intravenous cannula assembly
JP2006312034A (en) Nasolacrimal duct tube
JP5256491B2 (en) Endoscope device
KR101881191B1 (en) Lacrimal duct tube
US20050245950A1 (en) Method and apparatus to mark an incision
WO2011049198A1 (en) Tube device for insertion into lacrimal passage
US6547802B1 (en) Surgical blade
JP3120743U (en) Ophthalmic surgery knife
JP6616924B2 (en) Lacrimal tube
US8088134B2 (en) Ophthalmic marker for surgical retinal vitreous procedures
CN216417498U (en) Sclera puncture device
CN206777449U (en) Lamellar scleral flap size and shape marker in a kind of trabeculectomy for glaucoma operation
JP6502431B2 (en) Extra-thin tube needle for intrascleral fixation in intraocular lens
JP2005095571A (en) Improved medical syringe needle
CN215135498U (en) Distal structure of medical catheter
CN209933000U (en) Positioning marking device in operation
CN210044094U (en) Bladder puncture fistulization external member
CN215129340U (en) Integrated operation suture needle with blade
CN216148154U (en) Nondestructive puncture needle
CN203749980U (en) Puncturing guide and local anesthetizing needle head
JP6540956B2 (en) Ultrasound endoscope dilator

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090403

A131 Notification of reasons for refusal

Effective date: 20091215

Free format text: JAPANESE INTERMEDIATE CODE: A131

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100413